Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paschen

Showing results (531-540 of 570) with videos related to

Pageof 57
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|November 23, 2019
Deep Brain Stimulation for Freezing of Gait in Parkinson's Disease With Early Motor ComplicationsMichael T Barbe, Lisa Tonder, Paul Krack, et al.
Annals of Internal Medicine|May 7, 2020
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort StudyDominic Wichmann, Jan-Peter Sperhake, Marc Lütgehetmann, et al.
Frontiers in Immunology|September 25, 2020
Arenavirus Induced CCL5 Expression Causes NK Cell-Mediated Melanoma RegressionHilal Bhat, Gregor Zaun, Thamer A Hamdan, et al.
Parkinsonism & Related Disorders|September 18, 2022
Genetic stratification of motor and QoL outcomes in Parkinson's disease in the EARLYSTIM studyDaniel Weiss, Zied Landoulsi, Patrick May, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 3, 2022
The Contribution of Subthalamic Nucleus Deep Brain Stimulation to the Improvement in Motor Functions and Quality of LifeInken Tödt, Bassam Al-Fatly, Oliver Granert, et al.
The Journal of Clinical Investigation|May 20, 2020
Targeting the innate immunoreceptor RIG-I overcomes melanoma-intrinsic resistance to T cell immunotherapyLina Such, Fang Zhao, Derek Liu, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 26, 2024
A Short Progressive Supranuclear Palsy Quality of Life ScaleIda Wilkens, Stephanie Stiel, Sarah Bebermeier, et al.
Nature Cancer|July 31, 2023
Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanomaRenáta Váraljai, Lisa Zimmer, Yahya Al-Matary, et al.
European Journal of Cancer (Oxford, England : 1990)|August 30, 2024
Early versus late response to PD-1-based immunotherapy in metastatic melanomaGeorg C Lodde, Fang Zhao, Rudolf Herbst, et al.
Nature Immunology|December 11, 2019
Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activationStephen Zewinger, Jochen Reiser, Vera Jankowski, et al.
Pageof 57

Showing results (531-540 of 570) with videos related to

Sort By:
Pageof 57
Movement Disorders : Official Journal of the Movement Disorder Society|November 23, 2019
Deep Brain Stimulation for Freezing of Gait in Parkinson's Disease With Early Motor ComplicationsMichael T Barbe, Lisa Tonder, Paul Krack, et al.
Annals of Internal Medicine|May 7, 2020
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort StudyDominic Wichmann, Jan-Peter Sperhake, Marc Lütgehetmann, et al.
Frontiers in Immunology|September 25, 2020
Arenavirus Induced CCL5 Expression Causes NK Cell-Mediated Melanoma RegressionHilal Bhat, Gregor Zaun, Thamer A Hamdan, et al.
Parkinsonism & Related Disorders|September 18, 2022
Genetic stratification of motor and QoL outcomes in Parkinson's disease in the EARLYSTIM studyDaniel Weiss, Zied Landoulsi, Patrick May, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 3, 2022
The Contribution of Subthalamic Nucleus Deep Brain Stimulation to the Improvement in Motor Functions and Quality of LifeInken Tödt, Bassam Al-Fatly, Oliver Granert, et al.
The Journal of Clinical Investigation|May 20, 2020
Targeting the innate immunoreceptor RIG-I overcomes melanoma-intrinsic resistance to T cell immunotherapyLina Such, Fang Zhao, Derek Liu, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 26, 2024
A Short Progressive Supranuclear Palsy Quality of Life ScaleIda Wilkens, Stephanie Stiel, Sarah Bebermeier, et al.
Nature Cancer|July 31, 2023
Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanomaRenáta Váraljai, Lisa Zimmer, Yahya Al-Matary, et al.
European Journal of Cancer (Oxford, England : 1990)|August 30, 2024
Early versus late response to PD-1-based immunotherapy in metastatic melanomaGeorg C Lodde, Fang Zhao, Rudolf Herbst, et al.
Nature Immunology|December 11, 2019
Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activationStephen Zewinger, Jochen Reiser, Vera Jankowski, et al.
Pageof 57